AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018 Genomics Startup Emerges From Stealth Mode By Leading Harvard Geneticist February 8, 2018 BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017
Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018
BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017